GSTM1 and colorectal carcinoma: In the absence of IDA or palpable mass patients with f-Hb<10 μg Hb/g faeces have a very low risk of CRC, and those with f-Hb>400 μg Hb/g faeces had a 54% risk of significant bowel disease.6